Histiocytic Disorders (Record no. 28274)

MARC details
000 -LEADER
fixed length control field 02652nam a22002537a 4500
001 - CONTROL NUMBER
control field 20240813135520.0
003 - CONTROL NUMBER IDENTIFIER
control field 20240813135520.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240813135930.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240813b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-319-59631-0
International Standard Book Number 978-3-319-59632-7
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Oussama Abla
245 ## - TITLE STATEMENT
Title Histiocytic Disorders
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Toronto, Ontario, Canada :
Name of publisher, distributor, etc. Springer International Publishing AG :
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 390 Pages
Other physical details Includes References and Index
490 ## - SERIES STATEMENT
Series statement https://doi.org/10.1007/978-3-319-59632-7
520 ## - SUMMARY, ETC.
Summary, etc. This volume provides a comprehensive and world-class review of the field of histiocytic neoplasms and hemophagocytic lymphohistiocytosis (HLH). It reviews all the advances in the field of histiocytoses during the last ten years, particularly with regards to the genomic findings in LCH and other histiocytic neoplasms and the new suggested classification of the histiocytic disorders. Additionally, it features a state-of-the art update on the most recent treatment strategies for LCH, including the results of the last LCH-III international trial, salvage therapies such as reduced-intensity conditioning (RIC) stem cell transplant (SCT), and targeted therapies with BRAF and MEK inhibitors, as well as the challenging cases of CNS-neurodegenerative LCH and its therapeutic perspectives. For primary and secondary HLH the book updates the most recent genetic and pathophysiological findings, including macrophage-activation syndrome (MAS), and includes a special chapter on HLH in adults. Treatment chapters encompass therapy for newly diagnosed HLH and refractory disease as well as stem-cell transplantation and novel therapies. The text also highlights the most recent advances in the treatment of the uncommon histiocytic disorders, such as Erdheim-Chester disease (ECD), Juvenile xanthogranuloma (JXG) and JXG-like conditions, Rosai-Dorfman disease (RDD), and the very rare malignant histiocytoses.<br/><br/>Written by international experts in the field, Histiocytic Disorders is a valuable resource for clinicians, researchers, fellows and residents who are interested in or manage histiocytic disorders in children and adults.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Hematology, Medical / Clinical Medicine, Medical / Hematology, Medical / Oncology / General, Medical / Pathology, Oncology, Pathology, Blood -- Diseases, Immunologic diseases, Langerhans cells, Lymphatics -- Diseases, Macrophages, Medicine
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Gritta Janka
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-3-319-59632-7 ">https://doi.org/10.1007/978-3-319-59632-7 </a>
Link text https://doi.org/10.1007/978-3-319-59632-7
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 08/13/2024   20240813135520.0 08/13/2024 08/13/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024